StockData
Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc. (LUCD) stock

LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3078% above fair value
$0.45+0.03 (+7.88%)

Close on Nov 13, 2026Market cap $91.28MP/E –Yield –

Lucid Diagnostics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Lucid Diagnostics's profit margin for the twelve months ending Sep 30, 2026 was -892.8%. For fiscal 2025 it was -1232.7%, against -1047.6% the year before. The highest annual figure on record is -1047.6% in fiscal 2024.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1232.7%−185.1
FY2024Dec 31, 2024-1047.6%+1121.5
FY2023Dec 31, 2023-2169.1%+12730.4
FY2022Dec 31, 2022-14899.5%−9283.9
FY2021Dec 31, 2021-5615.6%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-555.0%+303.5
Q2 FY2026Jun 30, 2026-792.9%−411.2
Q1 FY2026Mar 31, 2026-1107.4%+2142.4
Q4 FY2025Dec 31, 2025-1081.5%−117.4
Q3 FY2025Sep 30, 2025-858.5%+197.0
Q2 FY2025Jun 30, 2025-381.7%+745.9
Q1 FY2025Mar 31, 2025-3249.8%−2189.6
Q4 FY2024Dec 31, 2024-964.2%+77.2
Q3 FY2024Sep 30, 2024-1055.5%+759.0
Q2 FY2024Jun 30, 2024-1127.6%+6030.3
Q1 FY2024Mar 31, 2024-1060.1%+2582.7
Q4 FY2023Dec 31, 2023-1041.3%+12287.2
Q3 FY2023Sep 30, 2023-1814.6%+17065.7
Q2 FY2023Jun 30, 2023-7157.9%−665.8
Q1 FY2023Mar 31, 2023-3642.8%+125.8
Q4 FY2022Dec 31, 2022-13328.6%−9850.1
Q3 FY2022Sep 30, 2022-18880.3%–
Q1 FY2022Mar 31, 2022-6492.1%–
Q4 FY2021Dec 31, 2021-3768.7%–
Q3 FY2021Sep 30, 2021-3478.5%–

More Lucid Diagnostics figures

See a number that looks wrong?